titanium has been researched along with indomethacin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sudmann, E | 1 |
| Kori-Lindner, C; Vergin, H | 1 |
| Brown, RC; Poole, A | 1 |
| Itooka, T; Matsuda, Y; Mitsuhashi, Y | 1 |
| Barrack, RL; Brown, TD; Cook, SD; Dalton, JE; Thomas, KA | 1 |
| Galante, JO; Glant, TT; Jacobs, JJ; Molnár, G; Shanbhag, AS; Valyon, M | 1 |
| Albrektsson, T; Kälebo, P; Sennerby, L; Thomsen, P | 1 |
| Blaine, TA; O'Keefe, RJ; Pollice, PF; Puzas, JE; Reynolds, PR; Rosier, RN | 1 |
| Batzer, R; Boyan, BD; Cochran, DL; Dean, DD; Liu, Y; Schwartz, Z; Szmuckler-Moncler, S | 1 |
| Chang, WH; Chen, LT; Hong, RC; Lin, FH; Liu, HC; Sun, JS; Tsuang, YH | 1 |
| Boyan, BD; Cochran, DL; Dean, DD; Lohmann, CH; Schwartz, Z; Simpson, JP; Sisk, MA; Sylvia, VL | 1 |
| Boyan, BD; Cochran, DL; Dean, DD; Liu, Y; Lohmann, CH; Schwartz, Z; Sisk, M; Sylvia, VL | 1 |
| Carpenter, LR; Fritz, EA; Glant, TT; Narayanan, R; Roebuck, KA; Vermes, C | 1 |
| Campbell, CM; Chuang, HH; Dean, DD; Gruwell, SF; Schmitz, JP; Sylvia, VL; Tindall, JW; Zhong, W | 1 |
| Atkins, GJ; Aw, MS; Findlay, DM; Gulati, K; Losic, D; Ramakrishnan, S | 1 |
| Addai-Mensah, J; Aw, MS; Losic, D | 1 |
| Addai-Mensah, J; Losic, D; Sinn Aw, M | 1 |
| Aw, MS; Losic, D | 1 |
| Aw, MS; Bariana, M; Losic, D; Moore, E; Voelcker, NH | 1 |
| Atkins, GJ; Findlay, DM; Gulati, K; Kogawa, M; Losic, D; Prideaux, M | 1 |
20 other study(ies) available for titanium and indomethacin
| Article | Year |
|---|---|
Vital microscopy of bone remodelling in rabbit ear chambers.
Topics: Animals; Bone and Bones; Bone Regeneration; Bone Resorption; Bone Transplantation; Culture Techniques; Ear, External; Female; Indomethacin; Male; Osteogenesis; Rabbits; Stimulation, Chemical; Titanium; Transplantation, Autologous | 1975 |
Putative mechanisms of cytoprotective effect of certain antacids and sucralfate.
Topics: Aluminum Hydroxide; Animals; Antacids; Dinoprostone; Dose-Response Relationship, Drug; Ethanol; Gastric Mucosa; Gastrointestinal Hemorrhage; Half-Life; Hydrogen-Ion Concentration; Indomethacin; Male; Osmolar Concentration; Rats; Rats, Inbred Strains; Silicic Acid; Stomach Diseases; Sucralfate; Titanium | 1990 |
Arachidonic acid release and prostaglandin synthesis in a macrophage-like cell line exposed to asbestos.
Topics: Arachidonic Acid; Arachidonic Acids; Asbestos; Asbestos, Crocidolite; Asbestos, Serpentine; Cell Line; Humans; Indomethacin; Macrophages; Prostaglandins; Titanium | 1984 |
Photostability of indomethacin in model gelatin capsules: effects of film thickness and concentration of titanium dioxide on the coloration and photolytic degradation.
Topics: Capsules; Color; Drug Stability; Gelatin; Indomethacin; Light; Titanium | 1980 |
Effects of indomethacin on biologic fixation of porous-coated titanium implants.
Topics: Animals; Bone and Bones; Dogs; Indomethacin; Osseointegration; Prostheses and Implants; Time Factors; Titanium | 1995 |
Bone resorption activity of particulate-stimulated macrophages.
Topics: Animals; Bone Resorption; Calcium; Cells, Cultured; Culture Media, Conditioned; Dinoprostone; Female; Indomethacin; Interleukin-1; Macrophages, Peritoneal; Methylmethacrylates; Mice; Mice, Inbred BALB C; Organ Culture Techniques; Particle Size; Phagocytosis; Polystyrenes; Recombinant Proteins; Titanium | 1993 |
Influence of indomethacin on the regeneration of cortical bone within titanium implants in rabbits.
Topics: Analysis of Variance; Animals; Densitometry; Female; Indomethacin; Male; Microradiography; Osseointegration; Prostheses and Implants; Rabbits; Tibia; Titanium | 1993 |
Modulation of the production of cytokines in titanium-stimulated human peripheral blood monocytes by pharmacological agents. The role of cAMP-mediated signaling mechanisms.
Topics: Bucladesine; Ciprofloxacin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Humans; In Vitro Techniques; Indomethacin; Interleukin-6; Monocytes; Phosphodiesterase Inhibitors; Prostaglandins E; Signal Transduction; Titanium; Tumor Necrosis Factor-alpha | 1997 |
Prostaglandins mediate the effects of titanium surface roughness on MG63 osteoblast-like cells and alter cell responsiveness to 1 alpha,25-(OH)2D3.
Topics: Alkaline Phosphatase; Calcitriol; Cell Line; Dinoprostone; Humans; Indomethacin; Osteoblasts; Osteocalcin; Surface Properties; Titanium; Transforming Growth Factor beta | 1998 |
Effect of anti-inflammatory medication on monocyte response to titanium particles.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Ciprofloxacin; Cytokines; Dinoprostone; Enzyme Inhibitors; Humans; Indomethacin; Interleukin-1; Interleukin-6; Materials Testing; Monocytes; Particle Size; Pentoxifylline; Titanium; Tumor Necrosis Factor-alpha | 2000 |
Inhibition of cyclooxygenase by indomethacin modulates osteoblast response to titanium surface roughness in a time-dependent manner.
Topics: Alkaline Phosphatase; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Autocrine Communication; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cells, Cultured; Culture Media, Conditioned; Cyclooxygenase Inhibitors; Dinoprostone; Extracellular Matrix; Humans; Indomethacin; Osteoblasts; Osteocalcin; Osteogenesis; Paracrine Communication; Plastics; Statistics as Topic; Surface Properties; Time Factors; Titanium; Transforming Growth Factor beta | 2001 |
Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness.
Topics: Alkaline Phosphatase; Biocompatible Materials; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Indomethacin; Isoenzymes; Materials Testing; Membrane Proteins; Nitrobenzenes; Osteoblasts; Osteocalcin; Phenotype; Prostaglandin-Endoperoxide Synthases; Resveratrol; Stilbenes; Sulfonamides; Surface Properties; Titanium; Transforming Growth Factor beta | 2001 |
Down-regulation of procollagen alpha1[I]] messenger RNA by titanium particles correlates with nuclear factor kappaB (NF-kappaB) activation and increased rel A and NF-kappaB1 binding to the collagen promoter.
Topics: Binding Sites; Cytokines; Dinoprostone; DNA-Binding Proteins; Down-Regulation; Humans; I-kappa B Proteins; Indomethacin; NF-kappa B; NF-KappaB Inhibitor alpha; Osteoblasts; Osteosarcoma; Procollagen; Promoter Regions, Genetic; RNA, Messenger; Signal Transduction; Titanium; Transcription Factor RelA; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2001 |
Arachidonic acid and prostaglandin E2 influence human osteoblast (MG63) response to titanium surface roughness.
Topics: Acid Etching, Dental; Alkaline Phosphatase; Arachidonic Acid; Bone Remodeling; Cell Count; Cell Differentiation; Cell Line; Cell Proliferation; Cells, Cultured; Cyclooxygenase Inhibitors; Dental Materials; Dinoprostone; DNA; Dose-Response Relationship, Drug; Humans; Indomethacin; Osteoblasts; Radiopharmaceuticals; Surface Properties; Thymidine; Time Factors; Titanium; Tritium | 2008 |
Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Cells, Cultured; Chitosan; Coated Materials, Biocompatible; Drug Carriers; Drug Delivery Systems; Humans; Indomethacin; Lactic Acid; Materials Testing; Nanotubes; Osteoblasts; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties; Titanium | 2012 |
A multi-drug delivery system with sequential release using titania nanotube arrays.
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Gentamicins; Humans; Hydrophobic and Hydrophilic Interactions; Indomethacin; Itraconazole; Micelles; Microscopy, Electron, Scanning; Nanotubes; Phosphatidylethanolamines; Polyethylene Glycols; Solubility; Titanium; Water | 2012 |
Polymer micelles for delayed release of therapeutics from drug-releasing surfaces with nanotubular structures.
Topics: Delayed-Action Preparations; Drug Carriers; Drug Compounding; Electrochemical Techniques; Gentamicins; Hydrophobic and Hydrophilic Interactions; Indomethacin; Kinetics; Micelles; Microscopy, Electron, Scanning; Nanotubes; Poloxamer; Polyethylene Glycols; Propylene Glycols; Solubility; Succinates; Titanium; Vitamin E | 2012 |
Ultrasound enhanced release of therapeutics from drug-releasing implants based on titania nanotube arrays.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Buffers; Drug Carriers; Drug Delivery Systems; Drug Implants; Equipment Design; Hydrogen-Ion Concentration; Indomethacin; Micelles; Microscopy, Electron, Scanning; Nanotubes; Particle Size; Sonication; Surface Properties; Titanium; Vitamin E | 2013 |
Radiofrequency-triggered release for on-demand delivery of therapeutics from titania nanotube drug-eluting implants.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Implants; Equipment Design; Gold; Indomethacin; Metal Nanoparticles; Micelles; Nanotubes; Radio Waves; Titanium; Transducers | 2014 |
Drug-releasing nano-engineered titanium implants: therapeutic efficacy in 3D cell culture model, controlled release and stability.
Topics: Animals; Cancellous Bone; Cattle; Cell Communication; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Cell Shape; Delayed-Action Preparations; Drug Liberation; Drug Stability; Gene Expression Regulation; Humans; Implants, Experimental; Indomethacin; Nanotechnology; Nanotubes; Osteoblasts; Parathyroid Hormone; Prostheses and Implants; Titanium | 2016 |